share_log

BTIG Reiterates Buy on Matinas BioPharma Hldgs, Maintains $3 Price Target

Benzinga ·  Oct 12, 2023 06:52

BTIG analyst Julian Harrison reiterates Matinas BioPharma Hldgs (AMEX:MTNB) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment